Contact
searchSearch
HMP Global

Pharmacy Learning Network

PharmLaw

PharmLaw
FTC Pauses Adjudication Against Caremark as Parties Pursue Consent Agreement in PBM Case
03/25/2026
Hannah Musick
The Federal Trade Commission (FTC) has paused its case against Caremark to consider a proposed settlement, signaling a potential early resolution in its broader enforcement action against pharmacy benefit managers (PBMs) while litigation...
The Federal Trade Commission (FTC) has paused its case against Caremark to consider a proposed settlement, signaling a potential early resolution in its broader enforcement action against pharmacy benefit managers (PBMs) while litigation...
The Federal Trade Commission...
03/25/2026
Pharmacy Learning Network
PharmLaw
Wholesale Pharmaceutical Executives Sentenced in $92 Million Drug Diversion Scheme
03/18/2026
Grace Taylor, MS, MA
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical...
03/18/2026
Pharmacy Learning Network
PharmLaw
Novo Nordisk Drops Patent Suit as Hims & Hers Shifts to FDA-Approved Semaglutide Products
03/11/2026
Hannah Musick
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its...
03/11/2026
Pharmacy Learning Network
PharmLaw
Louisiana Secures $45M Settlement With CVS, Caremark Over PBM Practices
03/04/2026
Grace Taylor, MS, MA
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million...
03/04/2026
Pharmacy Learning Network
PharmLaw
Federal Court Preliminarily Approves $5.275M Settlement in PharMerica Data Breach Class Action
02/27/2026
Grace Taylor, MS, MA
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has...
02/27/2026
Pharmacy Learning Network

FDA Recalls

News
Macleods Recalls Levothyroxine Sodium Tablets Due to Subpotency
04/02/2026
Hannah Musick
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is...
04/02/2026
Pharmacy Learning Network
News
Class II Recall Issued for Poractant Alfa Over Sterility Concerns
04/02/2026
Hannah Musick
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling...
04/02/2026
Pharmacy Learning Network
News
Teva Recalls Octreotide Injectable Suspensions Nationwide Over Sterility Concerns
04/02/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple lots of octreotide acetate injectable suspensions due to a lack of sterility assurance linked to manufacturing quality system deficiencies.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple lots of octreotide acetate injectable suspensions due to a lack of sterility assurance linked to manufacturing quality system deficiencies.
The US Food and Drug...
04/02/2026
Pharmacy Learning Network
News
Dexamethasone Sodium Phosphate Injection Recalled for Impurity Levels Above Specifications
03/26/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for dexamethasone sodium phosphate injection after stability testing revealed impurity levels above acceptable limits in a widely used injectable corticosteroid.
The US Food and Drug Administration (FDA) has issued a Class II recall for dexamethasone sodium phosphate injection after stability testing revealed impurity levels above acceptable limits in a widely used injectable corticosteroid.
The US Food and Drug...
03/26/2026
Pharmacy Learning Network
News
Bottles of Children’s Ibuprofen Recalled Nationwide Over Contamination Concerns
03/19/2026
Grace Taylor, MS, MA
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of...
03/19/2026
Pharmacy Learning Network

In the News

News
Macleods Recalls Levothyroxine Sodium Tablets Due to Subpotency
04/02/2026
Hannah Musick
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is...
04/02/2026
Pharmacy Learning Network
News
Class II Recall Issued for Poractant Alfa Over Sterility Concerns
04/02/2026
Hannah Musick
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling...
04/02/2026
Pharmacy Learning Network
News
Teva Recalls Octreotide Injectable Suspensions Nationwide Over Sterility Concerns
04/02/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple lots of octreotide acetate injectable suspensions due to a lack of sterility assurance linked to manufacturing quality system deficiencies.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple lots of octreotide acetate injectable suspensions due to a lack of sterility assurance linked to manufacturing quality system deficiencies.
The US Food and Drug...
04/02/2026
Pharmacy Learning Network
News
Dexamethasone Sodium Phosphate Injection Recalled for Impurity Levels Above Specifications
03/26/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for dexamethasone sodium phosphate injection after stability testing revealed impurity levels above acceptable limits in a widely used injectable corticosteroid.
The US Food and Drug Administration (FDA) has issued a Class II recall for dexamethasone sodium phosphate injection after stability testing revealed impurity levels above acceptable limits in a widely used injectable corticosteroid.
The US Food and Drug...
03/26/2026
Pharmacy Learning Network
PharmLaw
FTC Pauses Adjudication Against Caremark as Parties Pursue Consent Agreement in PBM Case
03/25/2026
Hannah Musick
The Federal Trade Commission (FTC) has paused its case against Caremark to consider a proposed settlement, signaling a potential early resolution in its broader enforcement action against pharmacy benefit managers (PBMs) while litigation...
The Federal Trade Commission (FTC) has paused its case against Caremark to consider a proposed settlement, signaling a potential early resolution in its broader enforcement action against pharmacy benefit managers (PBMs) while litigation...
The Federal Trade Commission...
03/25/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use